Tri­ci­da eye­ing sale, cost-cut­ting op­tions af­ter fail­ing high-stakes CKD wa­ger

Tri­ci­da is look­ing at all of its op­tions — not even two weeks af­ter watch­ing its stock nose­dive.

In an an­nounce­ment Wednes­day af­ter­noon, Tri­ci­da didn’t mince …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER